Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
Hawaii is the latest to introduce legislation aimed at closing coverage gaps, following similar action from Alabama, Arizona, California, Rhode Island and South Carolina.
The findings come from Sweden's Mammography Screening with Artificial Intelligence, or MASAI, a randomized clinical trial incorporating over 105,000 women.
There is limited research comparing HHUS and ABUS in second-look settings despite the fact that these exams are routinely utilized as supplemental imaging tools.
This reduction protocol allows for acceptable lesion visualization while also providing a cautionary cushion when the safety of sequential contrast injections is in question.
Although DBT exams are proven to identify more difficult to detect cancers, especially among women with dense breasts, they also include significantly more images than standard 2D mammograms.
The Class I recall, which is the most serious recall the FDA issues, comes after numerous adverse events and complications linked to the radiographic markers were reported.
UPDATED: The alert pertains to the BioZorb and BioZorb LP radiographic markers, implanted in soft tissue to indicate the site for radiation therapy or other medical procedures.
Although studies have shown AI to be effective as a support tool, several have also highlighted issues related to the potential for bias in algorithms that have not been trained on diverse datasets.
In individuals who have not completed a DEXA scan, head CT conducted for other reasons can offer insight into patients’ frontal bone density, a potential marker of osteoporosis.